Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2478-2487

  Verma, Anamika ^a   White, Mitchell ^a   Vathipadiekal, Vinod ^b   Tripathi, Shweta ^a   Mbianda, Julvet ^a   Ieong, Micheal ^a   Qi, Li ^c   Taubenberger, Jeffery K ^c   Takahashi, Kazue ^d   Jensenius, Jens C ^e   Thiel, Steffen ^e   Hartshorn, Kevan L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FICOLIN; H FICOLIN; OSELTAMIVIR; RECOMBINANT PROTEIN; SIALIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG POTENTIATION; DRUG TARGETING; HEMAGGLUTINATION INHIBITION; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; LUNG LAVAGE; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PROTEIN BINDING; SEASONAL INFLUENZA; SIALYLATION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS HEMAGGLUTINATION; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CELLS, CULTURED; COMPLEMENT FIXATION TESTS; DOGS; GLYCOPROTEINS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; LECTINS; MICE; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; SEASONS; VIRAL MATRIX PROTEINS; VIRUS REPLICATION;

EID: 84865404380     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103786     Document Type: Article

References (39)

1. Thiel, S. 2007. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol. Immunol. 44: 3875-3888.
2. Garred, P., and N. Borregaard. 2010. The ficolins. J. Innate Immun. 2: 1-2.
3. Akaiwa, M., Y. Yae, R. Sugimoto, S. O. Suzuki, T. Iwaki, K. Izuhara, and N. Hamasaki. 1999. Hakata antigen, a new member of the ficolin/opsonin p35 family, is a novel human lectin secreted into bronchus/alveolus and bile. J. Histochem. Cytochem. 47: 777-786.
4. Zacho, R. M., L. Jensen, R. Terp, J. C. Jensenius, and S. Thiel. 2012. Studies of the pattern recognition molecule H-ficolin: specificity and purification. J. Biol. Chem. 287: 8071-8081.
5. Sallenbach, S., S. Thiel, C. Aebi, M. Otth, S. Bigler, J. C. Jensenius, L. J. Schlapbach, and R. A. Ammann. 2011. Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr. Allergy Immunol. 22: 424-430.
6. Hummelshoj, T., L. M. Fog, H. O. Madsen, R. B. Sim, and P. Garred. 2008. Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen). Mol. Immunol. 45: 1623-1632.
7. Munthe-Fog, L., T. Hummelshøj, C. Honoré, H. O. Madsen, H. Permin, and P. Garred. 2009. Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N. Engl. J. Med. 360: 2637-2644.
8. Schlapbach, L. J., S. Thiel, U. Kessler, R. A. Ammann, C. Aebi, and J. C. Jensenius. 2011. Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis. Gut 60: 1438-1439.
9. Liu, J., M. A. Ali, Y. Shi, Y. Zhao, F. Luo, J. Yu, T. Xiang, J. Tang, D. Li, Q. Hu, et al. 2009. Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cell. Mol. Immunol. 6: 235-244.
10. Pan, Q., H. Chen, F. Wang, V. T. Jeza, W. Hou, Y. Zhao, T. Xiang, Y. Zhu, Y. Endo, T. Fujita, and X. L. Zhang. 2012. L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo. J. Innate Immun. 4: 312-324.
11. Keirstead, N. D., C. Lee, D. Yoo, A. S. Brooks, and M. A. Hayes. 2008. Porcine plasma ficolin binds and reduces infectivity of porcine reproductive and respiratory syndrome virus (PRRSV) in vitro. Antiviral Res. 77: 28-38.
12. Chang,W. C., K. L. Hartshorn, M. R. White, P. Moyo, I. C. Michelow, H. Koziel, B. T. Kinane, E. V. Schmidt, T. Fujita, and K. Takahashi. 2011. Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem. Pharmacol. 81: 388-395.
13. Michelow, I. C., M. Dong, B. A. Mungall, L. M. Yantosca, C. Lear, X. Ji, M. Karpel, C. L. Rootes, M. Brudner, G. Houen, et al. 2010. A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. J. Biol. Chem. 285: 24729-24739.
14. Krarup, A., S. Thiel, A. Hansen, T. Fujita, and J. C. Jensenius. 2004. L-ficolin is a pattern recognition molecule specific for acetyl groups. J. Biol. Chem. 279: 47513-47519.
15. Hartshorn, K. L., M. Collamer, M. Auerbach, J. B. Myers, N. Pavlotsky, and A. I. Tauber. 1988. Effects of influenza A virus on human neutrophil calcium metabolism. J. Immunol. 141: 1295-1301.
16. Frederiksen, P. D., S. Thiel, C. B. Larsen, and J. C. Jensenius. 2005. M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand. J. Immunol. 62: 462-473.
17. Kuraya, M., Z. Ming, X. Liu, M. Matsushita, and T. Fujita. 2005. Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology 209: 689-697.
18. Hartshorn, K. L., E. C. Crouch, M. R. White, P. Eggleton, A. I. Tauber, D. Chang, and K. Sastry. 1994. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J. Clin. Invest. 94: 311-319.
19. Tecle, T., M. R. White, D. Gantz, E. C. Crouch, and K. L. Hartshorn. 2007. Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J. Immunol. 178: 8046-8052.
20. Hartshorn, K., K. Sastry, D. Chang, M. White, and E. Crouch. 2000. Enhanced antinfluenza activity of a recombinant pulmonary surfactant protein D and serum conglutinin fusion protein. Am. J. Physiol. 278: L90-L98.
21. Hartshorn, K. L., M. R. White, V. Shepherd, K. Reid, J. C. Jensenius, and E. C. Crouch. 1997. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am. J. Physiol. 273: L1156-L1166.
22. Qi, L., J. C. Kash, V. G. Dugan, B. W. Jagger, Y. F. Lau, Z. M. Sheng, E. C. Crouch, K. L. Hartshorn, and J. K. Taubenberger. 2011. The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding. Virology 412: 426-434.
23. Job, E. R., Y. M. Deng, M. D. Tate, B. Bottazzi, E. C. Crouch, M. M. Dean, A. Mantovani, A. G. Brooks, and P. C. Reading. 2010. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J. Immunol. 185: 4284-4291.
24. Hartshorn, K. L., K. Sastry, M. R. White, E. M. Anders, M. Super, R. A. Ezekowitz, and A. I. Tauber. 1993. Human mannose-binding protein functions as an opsonin for influenza A viruses. J. Clin. Invest. 91: 1414-1420.
25. Reading, P. C., L. S. Morey, E. C. Crouch, and E. M. Anders. 1997. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J. Virol. 71: 8204-8212.
26. Reading, P. C., S. Bozza, B. Gilbertson, M. Tate, S. Moretti, E. R. Job, E. C. Crouch, A. G. Brooks, L. E. Brown, B. Bottazzi, et al. 2008. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J. Immunol. 180: 3391-3398.
27. Hartshorn, K. L., A. Ligtenberg, M. R. White, M. Van Eijk, M. Hartshorn, L. Pemberton, U. Holmskov, and E. Crouch. 2006. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem. J. 393: 545-553.
28. White, M. R., E. J. Helmerhorst, A. Ligtenberg, M. Karpel, T. Tecle, W. L. Siqueira, F. G. Oppenheim, and K. L. Hartshorn. 2009. Multiple components contribute to ability of saliva to inhibit influenza viruses. Oral Microbiol. Immunol. 24: 18-24.
29. White, M. R., E. Crouch, M. van Eijk, M. Hartshorn, L. Pemberton, I. Tornoe, U. Holmskov, and K. L. Hartshorn. 2005. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L831-L840.
30. Garlatti, V., L. Martin, M. Lacroix, E. Gout, G. J. Arlaud, N. M. Thielens, and C. Gaboriaud. 2010. Structural insights into the recognition properties of human ficolins. J. Innate Immun. 2: 17-23.
31. Hartshorn, K. L., M. R. White, T. Mogues, T. Ligtenberg, E. Crouch, and U. Holmskov. 2003. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L1066-L1076.
32. Ma, Y. J., A. Doni, T. Hummelshøj, C. Honoré, A. Bastone, A. Mantovani, N. M. Thielens, and P. Garred. 2009. Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition. J. Biol. Chem. 284: 28263-28275.
33. Benne, C. A., C. A. Kraaijeveld, J. A. G. van Strijp, E. Brouwer, M. Harmsen, J. Verhoef, L. M. G. van Golde, and J. F. van Iwaarden. 1995. Interactions of surfactant protein A with influenza A viruses: binding and neutralization. J. Infect. Dis. 171: 335-341.
34. van Eijk, M., M. R. White, E. C. Crouch, J. J. Batenburg, A. B. Vaandrager, L. M. Van Golde, H. P. Haagsman, and K. L. Hartshorn. 2003. Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain. J. Immunol. 171: 1431-1440.
35. Gout, E., C. Moriscot, A. Doni, C. Dumestre-Pérard, M. Lacroix, J. Pérard, G. Schoehn, A. Mantovani, G. J. Arlaud, and N. M. Thielens. 2011. M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules. J. Immunol. 186: 5815-5822.
36. Mikerov, A. N., M. White, K. Hartshorn, G. Wang, and J. Floros. 2008. Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells. Med. Microbiol. Immunol. (Berl.) 197: 9-12.
37. Hartshorn, K. L. 2010. Role of surfactant protein A and D (SP-A and SP-D) in human antiviral host defense. Front Biosci (Schol Ed) 2: 527-546 (Schol Ed).
38. Hartshorn, K. L., M. R. White, D. R. Voelker, J. Coburn, K. Zaner, and E. C. Crouch. 2000. Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem. J. 351: 449-458.
39. Endo, Y., Y. Liu, K. Kanno, M. Takahashi, M. Matsushita, and T. Fujita. 2004. Identification of the mouse H-ficolin gene as a pseudogene and orthology between mouse ficolins A/B and human L-/M-ficolins. Genomics 84: 737-744.